Abstract
The development of acute myelogenous leukemia (AML), which is characterized by a block of myeloid differentiation, is a multi-step process that involves several genetic abnormalities, but the molecular mechanisms by which these genetic alterations cooperate in leukemogenesis are poorly understood. The human chronic myelogenous leukemia (CML) is a model for multi-step leukemogenesis. BCR-ABL, a constitutively active tyrosine kinase, is a fusion protein generated by the t(9;22)(q34;q11) translocation found in the vast majority of CML patients. BCR-ABL efficiently induces a myeloproliferative disorder (MPD) in mice, but progression to CML blast phase requires additional mutations. The AML1/MDS1/EVI1 (AME) transcription factor fusion protein, is a product of the human t(3;21)(q26;q22) translocation found as a secondary mutation in some cases of CML during the blast phase. We have previously shown that AME can induce an AML in mice but with a greatly extended latency, suggesting a requirement for additional mutations. Here we demonstrate that AME alone does not block myeloid differentiation in vivo during the 4-month pre-leukemia stage, yet co-expression of BCR-ABL and AME in mice can block myeloid differentiation and rapidly induce an AML. Our results suggest that block of myeloid differentiation and induction of AML involves cooperation between mutations that dysregulate protein tyrosine kinase signaling and those that disrupt hematopoietic gene transcription.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
£169.00 per year
only £3.38 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahuja HG, Foti A, Bar-Eli M, Cline MJ . 1990 Blood 75: 1684–1690
Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, Owens J, Eckhaus M, Bodine D, Liu PP . 1999 Nat. Genet. 23: 144–146
Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP . 1996 Cell 87: 687–696
Cuenco GM, Nucifora G, Ren R . 2000 Proc. Natl. Acad. Sci. USA 97: 1760–1765
Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM . 1999 N. Engl. J. Med. 341: 164–172
Fialkow PJ, Janssen JW, Bartram CR . 1991 Blood 77: 1415–1417
Frederickson TN, Harris AW . 2000 Atlas of Mouse Hematopathology Gordon and Breach, Amsterdam, The Netherlands
Goldman JM . 1997 Curr. Opin. Hematol. 4: 277–285
Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . 2001 Science 293: 876–880
Gross AW, Zhang X, Ren R . 1999 Mol. Cell. Biol. 19: 6918–6928
Hao SX, Ren R . 2000 Mol. Cell. Biol. 20: 1149–1161
Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P . 2000 Hematology: Basic Principles and Practice, 3rd edn Churchill Livingstone, Philadelphia, Pennsylvania
Horiike S, Yokota S, Nakao M, Iwai T, Sasai Y, Kaneko H, Taniwaki M, Kashima K, Fujii H, Abe T, Misawa S . 1997 Leukemia 11: 1442–1446
Heuttner CS, Zhang P, Van Etten RA, Tenen DG . 2000 Nat. Genet. 24: 57–60
Jacobs A . 1991 Leukemia 5: 277–282
Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H, Naoe T . 1998 Leukemia 12: 1333–1337
Kreider BL, Orkin SH, Ihle JN . 1993 Proc. Natl. Acad. Sci. USA 90: 6454–6458
Li S, Ilaria Jr RL, Million RP, Daley GQ, Van Etten RA . 1999 J. Exp. Med. 189: 1399–1412
Louz D, van den Broek M, Verbakel S, Vankan Y, van Lom K, Joosten M, Meijer D, Lowenberg B, Delwel R . 2000 Leukemia 14: 1876–1884
Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H . 1994 EMBO J. 13: 504–510
Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T, Misawa S . 1996 Leukemia 10: 1911–1918
Neubauer A, Dodge RK, George SL, Davey FR, Silver RT, Schiffer CA, Mayer RJ, Ball ED, Wurster-Hill D, Bloomfield CD . 1994 Blood 83: 1603–1611
Niki M, Okada H, Takano H, Kuno J, Tani K, Hibino H, Asano S, Ito Y, Satake M, Noda T . 1997 Proc. Natl. Acad. Sci. USA 94: 5697–5702
Nucifora G . 1997 Leukemia 11: 2022–2031
Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD . 1994 Proc. Natl. Acad. Sci. USA 91: 4004–4008
Nucifora G, Birn DJ, Espinosa RD, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD . 1993 Blood 81: 2728–2734
Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR . 1998 Blood 91: 3134–3143
Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . 1996 Cell 84: 321–330
Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . 1998 Blood 92: 3780–3792
Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B . 1998 EMBO J. 17: 4442–4455
Sawyers CL . 1999 N. Engl. J. Med. 340: 1330–1340
Sood R, Talwar-Trikha A, Chakrabarti SR, Nucifora G . 1999 Leukemia 13: 348–357
Tanaka A, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H . 1995a Mol. Cell. Biol. 15: 2383–2392
Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H . 1995b EMBO J. 14: 341–350
Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . 1996 Cell 87: 697–708
Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW . 1998 Mol. Cell. Biol. 18: 322–333
Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, Asou N, Kuriyama K, Yagasaki F, Shimazaki C, Akiyama H, Saito K, Nishimura M, Motoji T, Shinagawa K, Takeshita A, Saito H, Ueda R, Ohno R, Naoe T . 2001 Blood 97: 2434–2439
Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE . 1997 Nat. Genet. 15: 303–306
Yokota S, Kiyoi H, Nakao M, Iwai T, Misawa S, Okuda T, Sonoda Y, Abe T, Kahsima K, Matsuo Y, Naoe T . 1997 Leukemia 11: 1605–1609
Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K, Zhang DE . 2001 Proc. Natl. Acad. Sci. USA 98: 10398–10403
Zhang X, Ren R . 1998 Blood 92: 3829–3840
Acknowledgements
We are grateful to Jennifer Joyce for technical assistance and to Mike Jennings and Glenn Paradis for assistance and advice in flow cytometry cell sorting. GM Cuenco is supported by the National Institutes of Health Training Grant GM07122. R Ren is a recipient of the Leukemia Society of America Scholar Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cuenco, G., Ren, R. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene 20, 8236–8248 (2001). https://doi.org/10.1038/sj.onc.1205095
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205095